Disposition Characteristics of Mitomycin C-Dextran Conjugate in Normal and Tumor-bearing Muscles of Rabbits

Cancer Research

Volumn 47, Issue 21, 1987, Pages 5546-5551

  Atsumi, Ryo ^a   Endo, Kaori ^a   Kakutani, Toshiyuki ^a   Takakura, Yoshinobu ^a   Hashida, Mitsuru ^a   Sezaki, Hitoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; PRODRUG;

ANIMAL EXPERIMENT; DRUG CONJUGATE; MUSCLE; NONHUMAN; RABBIT; TUMOR BEARING ANIMAL;

ANIMAL; DEXTRANS; MALE; MITOMYCIN; MITOMYCINS; MUSCLES; NEOPLASMS, EXPERIMENTAL; RABBITS; SERUM ALBUMIN; SUPPORT, NON-U.S. GOV'T;

EID: 0023603229     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kojima, T., Hashida, M., Muranishi, S., and Sezaki, H. Mitomycin C-dextran conjugate: a novel high molecular weight prodrug of mitomycin C. J. Pharm. Pharmacol., 32:30-34,1980.
2. Takakura, Y., Kitajima M., Matsumoto, S., Hashida, M., and Sezaki, H. Development of novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge, I. Physicochemical characteristics and in vivo and in vitro antitumor activities. Int. J. Pharm. (Amst), 37:135-143, 1987.
3. Hashida, M., Kato, A., Muranishi, S., Sezaki, H., Tanigawa, N., Satomura, K., and Hikasa, Y. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors. Gann, 72:226-234, 1981.
4. Kato, A., Takakura, Y., Hashida, M., Kimura, T., and Sezaki, H. Physicochemical and antitumor characteristics of high molecular weight prodrugs of mitomycin C. Chem. Pharm. Bull. (Tokyo), 30:2951-2957,1982.
5. Takakura, Y., Matsumoto, S., Hashida, M., and Sezaki, H. Enhanced lymphatic delivery of mitomycin C conjugated with dextran. Cancer Res., 44: 2505-2510,1984.
6. Takakura, Y., Mori, K., Hashida, M., and Sezaki, H. Absorption characteristics of macromolecular prodrug of mitomycin C following intramuscular administration. Chem. Pharm. Bull. (Tokyo), 34:1775-1783,1986.
7. Kakutani, T., Yamaoka, K., Hashida, M., and Sezaki, H. A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion system. J. Pharmacokinet. Biopharm., 13: 609-631,1985.
8. Dewey, W. C. Vascular-extravascular exchange of 1311 plasma proteins in the rat Am. J. Physiol., 197:423-431,1959.
9. Ackerman, N. B., and Hechmer, P. A. Studies on the capillary permeability of experimental liver metastases. Surg. Gynecol. Obstet., 146:884-888,1978.
10. O’Connor, S. W., and Bale, W. F. Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. Cancer Res., 44: 3719-3723,1984.
11. Matsumura, S., and Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 46:6387-6392,1986.
12. Sezaki, H., and Hashida, M. Macromolecule-drug conjugates in targeted cancer chemotherapy. CRC Crit. Rev. Ther. Drug Carrier Syst., 1: 1–38, 1984.
13. Hashida, M., Kato, A., Takakura, Y., and Sezaki, H. Disposition and pharmacokinetics of polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate in the rat. Drug Metab. Dispos., 12:492-499,1984.
14. Tyrode, M. V. The mode of action of some purgative salts. Arch. Int. Pharmacodyn. Ther., 20:205-223,1910.
15. Mahin, D. T., and Loftberg, R. T. A simplified method of sample preparation for determination of tritium, carbon-14 or sulfur-35 in blood or tissue by liquid scintillation counting. Anal. Biochem., 16:500-509,1966.
16. Bischoff, K. B., and Dedrick, R. L. Thiopental pharmacokinetics. J. Pharm. Sci., 57; 1346-1351,1968.
17. Taylor, A. E., and Granger, D. N. Equivalent pore modeling: vesicles and channels. Fed. Proc., 42:2440-2445, 1983.
18. Garlick, D. G., and Renkin, E. M. Transport of large molecules from plasma to interstitial fluid and lymph in dogs. Am. J. Physiol., 219: 1595–1605, 1970.
19. Matsumoto, S., Yamamoto, A., Takakura, Y., Hashida, M., Tanigawa, N., and Sezaki, H. Cellular interaction and in vitro antitumor activity of mitomycin C-dextran conjugate. Cancer Res., 46:4463-4468,1986.
20. Gullino, P. M., and Grantham, F. H. Studies on exchange of fluids between host and tumor. II. The blood flow of hepatomas and other tumors in rats and mice. J. Natl. Cancer Inst., 27:1465-1491,1961.
21. Cataland, S., Cohen, C., and Sapirstein, L. A. Relationship between size and perfusion rate of transplanted tumors. J. Natl. Cancer Inst., 29: 389–394, 1962.
22. Butler, T. P., Grantham, F. H., and Gullino, P. M. Bulk transfer of fluid in the interstitial compartment of mammary tumors. Cancer Res., 35: 3084-3088,1975.
23. Wiig, H., Tveit, E., Hultbom, R., Reed, R. K., and Weiss, L. Interstitial fluid pressure in DM BA-induced rat mammary tumors. Scand. J. Clin. Lab. Invest., 42:159-164, 1982.
24. Hori, K., Suzuki, M., Abe, I., and Saito, S. Increased tumor tissue pressure in association with growth of rat tumors. Jpn. J. Cancer Res., 77: 65–73, 1986.
25. Blasberg, R., Horowitz, M., Strong, J., Molnar, P., Patlak, C., Owens, E., and Fenstermacher, J. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors. Cancer Res., 45:1692-1701,1985.
26. Townsend, J. G., Jain, R. K., and Cashmore, A. R. In vivo pharmacokinetics of triazinate in L-1210 and W-256 cells. J. Pharm. Sci., 71: 1102–1105, 1982.
27. Farris, F. F., King, F. G., Dedrick, R. L., and Litterst, C. L. Physiological model for the pharmacokinetics of cis-dichlorodiamine platinum(II) in the tumored rat J. Pharmacokinet. Biopharm., 13:13-39,1985.
28. Jain, R. K., Wei, J., and Gullino, P. M. Pharmacokinetics of methotrexate in solid tumors. J. Pharmacokinet Biopharm., 7: 181-194,1979.
29. Levin, V. A., Patlak, C. S., and Landahl, H. D. Heuristic modeling of drug delivery to malignant brain tumors. J. Pharmacokinet. Biopharm., 8: 257-258, 1980.
30. Gullino, P. M., and Grantham, F. H. Studies on the exchange of fluids between host and tumor. III. Regulation of blood flow in hepatomas and other rat tumors. J. Natl. Cancer Inst., 28:211-229,1962.
31. Watters, C., and Gullino, P. M. Translocation of DNA from the vascular into nuclear compartment of solid mammary tumors. Cancer Res., 31:1231—1243, 1971.
32. Folkman, J., Cole, P., and Zimmerman, S. Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment Ann. Surg., 164:491-502,1966.
33. Liotta, L. A., Kleinerman, J., and Saidel, G. M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res., 34:997-1004,1974.
34. Song, C. W., and Levitt, S. H. Quantitative study of vascularity in Walker carcinoma 256. Cancer Res., 31:587-589,1971.
35. Endrich, B., Reinhold, H. S., Gross, J. F., and Intaglietta, M. Tissue perfusion inhomogeneity during early tumor growth in rats. J. Natl. Cancer Inst., 62: 387-395,1979.
36. Oberfield R. A., McCaffrey, J. A., Polio, J., Clouse, M. E., and Hamilton, T. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer (Phila.), 44:414-423,1979.
37. Chen, H. S. G., and Gross, J. F. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep., 64:31-40,1980.
38. Takakura, Y., Atsumi, R., Hashida, M., and Sezaki, H. Development of novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administration. Int. J. Pharmaceut, 37:145-154, 1987.
39. Takakura, Y., Takagi, A., Hashida, M., and Sezaki, H. Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharm. Res., 4:293-300, 1987.